Latest Form 4 insider transactions

Richard A Maue, a Director of Federal Signal Corp /De/, received 108 shares of common stock on September 25, 2026.

Gregory R. Alexander, CEO of Syra Health Corp, received 368,458 shares of common stock on August 11, 2026.

Gregory R. Alexander, CEO of Syra Health Corp, reported multiple transactions in common stock on January 5, 2026.

Stephen P Mawer, a Director of Calumet, Inc. /DE, sold 24,555 shares of common stock on September 25, 2026.

Cynthia Egan, a Director of Hanover Insurance Group, Inc., received 4 shares of common stock on September 25, 2026.

John C Malone, a 10% owner of Liberty Live Holdings, Inc., reported multiple transactions in common stock on September 24, 2026.

William E. Donnell, a Director of Hanover Insurance Group, Inc., received 4 shares of common stock on September 25, 2026.

Michael H Tardugno, Executive Chairman of Board and a Director of Imunon, Inc., received 7,169 shares of common stock on September 25, 2026.

J Paul Condrin, a Director of Hanover Insurance Group, Inc., received 4 shares of common stock on September 25, 2026.

TDR Capital II Investments LP and 9 others reported changes in beneficial ownership of Target Hospitality Corp. common stock on September 25, 2026.

Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on September 25, 2026.

Heidi O'Neill, a Director of Lithia Motors Inc, reported a transaction in 540 shares of common stock on September 25, 2026.

Theodore H Bunting Jr, a Director of Hanover Insurance Group, Inc., received 4 shares of common stock on September 25, 2026.

Sudarshan Hebbar, Chief Medical Officer of CalciMedica, Inc., received 180,000 shares of common stock on September 24, 2026.

Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc., received 4,390 shares of common stock on September 25, 2026.

Kevin Bradicich, a Director of Hanover Insurance Group, Inc., received 4 shares of common stock on September 25, 2026.

Kenneth A. Stauderman, Chief Scientific Officer of CalciMedica, Inc., received 180,000 shares of common stock on September 24, 2026.

Francisco Aristeguieta, a Director of Hanover Insurance Group, Inc., received 4 shares of common stock on September 25, 2026.

Elizabeth A Ward, a Director of Hanover Insurance Group, Inc., received 4 shares of common stock on September 25, 2026.

Stephen Bardin, Chief Financial Officer of CalciMedica, Inc., received 190,000 shares of common stock on September 24, 2026.

Esta E Stecher, a Director of Jackson Financial Inc., received 355 shares of common stock on September 24, 2026.

Drew Lawton, a Director of Jackson Financial Inc., received 208 shares of common stock on September 24, 2026.

Derek G Kirkland, a Director of Jackson Financial Inc., received 103 shares of common stock on September 24, 2026.

Steven A Kandarian, a Director of Jackson Financial Inc., received 784 shares of common stock on September 24, 2026.

Bryan J Salvatore, Executive Vice President of Hanover Insurance Group, Inc., received 24 shares of common stock on September 25, 2026.

Hartree Partners, LP reported changes in beneficial ownership of Hudson Technologies Inc /Ny common stock on September 24, 2026.

Lily Fu Claffee, a Director of Jackson Financial Inc., received 329 shares of common stock on September 24, 2026.

A. Rachel Leheny, CHIEF EXECUTIVE OFFICER and a Director of CalciMedica, Inc., received 360,000 shares of common stock on September 24, 2026.

John C Roche, President and CEO and a Director of Hanover Insurance Group, Inc., received 120 shares of common stock on September 25, 2026.

Preston Wendell Wells, VP, Chief Financial Officer of Stryker Corp, reported a transaction in 109 shares of common stock on September 24, 2026.